Mirko Olivo

545 citations
8 papers · 306 indexed · h-index 6
Topics
Inflammatory Bowel Disease (3 papers)Liver Disease and Transplantation (2 papers)Hepatocellular Carcinoma Treatment and Prognosis (2 papers)

In The Last Decade

Mirko Olivo

8 papers receiving 295 citations

Peers

Mirko Olivo
Comparison fields: 5 of 40
  • Hepatology 187
  • Epidemiology 176
  • Surgery 88
  • Genetics 67
  • Pulmonary and Respiratory Medicine 34
Replace Yoshimasa Yamashita with:
Yoshimasa Yamashita Japan
Laurent Possenti France
Teppei Yoshioka Japan
Antonio Cassata Italy
Naruhiro Yamasaki Japan
Sepideh Besharati United States
Mina Farag Canada
Ahmed A. Abdel-Kader Egypt
Akeri Mitsuda Japan
Anna Maria Croce Italy
Mirko Olivo relative to Yoshimasa Yamashita Japan Yoshimasa Yamashita's profile →
Citations per field
00.5×6.7×
Yoshimasa Yamashita · 1×
Citations per year

Countries citing papers authored by Mirko Olivo

Since Specialization
Citations

This map shows the geographic impact of Mirko Olivo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirko Olivo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirko Olivo more than expected).

Fields of papers citing papers by Mirko Olivo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirko Olivo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirko Olivo. The network helps show where Mirko Olivo may publish in the future.

Co-authorship network of co-authors of Mirko Olivo

This figure shows the co-authorship network connecting the top 25 collaborators of Mirko Olivo. A scholar is included among the top collaborators of Mirko Olivo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirko Olivo. Mirko Olivo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 24
2
Is really megacolon a contraindication to infliximab in Crohn's disease?
2
3 1
4 61
5 182
6 17
7 13
8 6

About Mirko Olivo

Mirko Olivo is a scholar working on Hepatology, Genetics and Genetics, having authored 8 papers that have together received 306 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (3 papers), Liver Disease and Transplantation (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Hepatology (187 citations), Epidemiology (176 citations) and Gastroenterology (18 citations). Mirko Olivo has collaborated with scholars based in Italy, Argentina and United States. Frequent co-authors include Mario Cottone, Ambrogio Orlando, Angelo Andriulli, Gioacchino Leandro, Filippo Mocciaro, Daniela Scimeca, Rosalba Orlando, Luigi Maria Montalbano, Gennaro D’Amico and Salvatore Madonia. Their work appears in journals such as The American Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics and Digestive Diseases and Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026